CINECA 

(Common Infrastructure for National Cohorts in Europe, Canada, and Africa)

CINECA’s vision is a federated, cloud-enabled infrastructure making population-scale genomic and biomolecular data accessible across international borders, accelerating research and improving the health of individuals across continents. CINECA will leverage international investment in human cohort studies from Europe, Canada and Africa to deliver a paradigm shift of federated research and clinical applications. CINECA will create one of the largest cross-continental implementations of human genetic and phenotypic data federation and interoperability with a focus on common (complex) disease.

Start date: 1 January 2019 | End date: 31 December 2019

EUCANCan

(European Canadian Cancer Network) 

EUCANCan aims to build a federated infrastructure across EU and Canada to enable personalized medicine in oncology by the generation and sharing of harmonized genomic and phenotypic data. EUCANCan builds on work performed by its consortium members and related projects to align and interconnect existing infrastructures for the analysis and management of genomic oncology data. The EUCANCan network will be composed of reference nodes in Amsterdam, Barcelona, Berlin, Heidelberg, Paris and Toronto with strong research and clinical programs in the field of genomic oncology.

Start date: 1 January 2019 | End date: 31 December 2022

euCanShare

An EU-Canada joint infrastructure for next-generation multi-Study Heart research

euCanSHare is a H2020 project that aims at developing a translational research platform for cardiovascular data sharing between the EU and Canada. Once established, researchers will benefit from a consolidated one-stop, integrated resource to perform efficient and effective research based on data-driven approaches linking molecular, imaging, functional and clinical data. The end goal is tailor-made patient treatment and better cardiovascular disease outcomes. The project integrates more than 35 Canadian and European cohorts that make up over 1 million records, including -omics (genomics, transcriptomics, metabolomics, etc.), cardiac imaging and clinical data.

Start date: 1 December 2018 | End date: 30 November 2022

EUCAN-Connect

(A federated FAIR platform enabling large-scale analysis of high-value cohort data connecting Europe and Canada in personalized health)

EUCAN-Connect will enable large-scale integrated cohort data analysis for personalized and preventive healthcare across EU and Canada. This will be based on an open, scalable data platform for cohorts, researchers and networks, incorporating FAIR principles (Findable, Accessible, Interoperable, Reusable) for optimal reuse of existing data, and building on maturing federated technologies, with sensitive data kept locally and only results being shared and integrated, in line with key ELSI and governance guidelines.

Start date: 1 January 2019 | End date: 31 December 2023

iReceptor Plus

(Architecture and tools for the query of antibody and t-cell receptor sequencing data repositories for enabling improved personalized medicine and immunotherapy)

iReceptor Plus aims to facilitate the sharing of AIRR-seq data among multiple institutions for a better understanding of the causes of infectious and autoimmune diseases and cancer. Its consortium of researchers from EU and Canada will address several key challenges to the optimal sharing of AIRR-seq data among public and industrial partners, such as patient privacy, intellectual property, data integration and harmonisation, to support early detection, identification of novel therapies and possibly reduce the social and economic burden of these diseases worldwide.

Start date: 1 January 2019 | End date: 31 December 2022